Ascendis Pharma is a global biopharmaceutical company focused on applying our innovative TransCon technology platform to make a meaningful difference for patients. Guided by our core values of Patients, Science, and Passion, and following our algorithm for product innovation, we apply TransCon to develop new therapies that demonstrate best-in-class potential to address unmet medical needs. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States. Please visit ascendispharma.com to learn more.
Looking for a particular Ascendis Pharma employee's phone or email?
The Ascendis Pharma annual revenue was $345.2 million in 2026.
Lars Pettersson is the CIO of Ascendis Pharma.
1,130 people are employed at Ascendis Pharma.
The NAICS codes for Ascendis Pharma are [32541, 3254, 325, 32].
The SIC codes for Ascendis Pharma are [283, 28].